# EDGAR Filing Document

**Accession Number:** 0000707549
**File Stem:** 0000707549-23-000011
**Filing Date:** 2023-2
**Character Count:** 29270
**Document Hash:** e8f11cfaa1056089755686a2baa11d7d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000707549-23-000011.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0000707549-23-000011

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230207

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LAM RESEARCH CORP
- **CENTRAL INDEX KEY:** 0000707549
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIAL INDUSTRY MACHINERY, NEC [3559]
- **IRS NUMBER:** 942634797
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0625

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-12933
- **FILM NUMBER:** 23606543

**BUSINESS ADDRESS:**
- **STREET 1:** 4650 CUSHING BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
- **BUSINESS PHONE:** 5106590200

**MAIL ADDRESS:**
- **STREET 1:** 4650 CUSHING PARKWAY
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538

?xml version="1.0" ? lrcx-20230207

<u>[**Table of Contents**](#i3cd56b2dadf3494f902af376ecd730e3_7)</u>

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM 8-K** 

**Current Report**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): February 7, 2023** 

**LAM RESEARCH CORPORATION** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-12933** | **94-2634797** |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission<br>File Number)** | **(IRS Employer<br>Identification Number)** |

---

**4650 Cushing Parkway** 

**Fremont, California 94538** 

**(Address of principal executive offices including zip code)**

**(510) 572-0200** 

**(Registrant's telephone number, including area code)**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Common Stock, Par Value $0.001 Per Share | LRCX | The Nasdaq Stock Market |
|  |  | (Nasdaq Global Select Market) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company &nbsp;&nbsp;&nbsp;&nbsp; ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; ☐

------

<u>[**Table of Contents**](#i3cd56b2dadf3494f902af376ecd730e3_7)</u>

 **Table of Contents**

---

| | | |
|:---|:---|:---|
| Item 5.02. | <u>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</u> | <u>[3](#i3cd56b2dadf3494f902af376ecd730e3_10)</u> |
| Item 9.01. | <u>Financial Statements and Exhibits</u> | <u>[4](#i3cd56b2dadf3494f902af376ecd730e3_16)</u> |
| <u>SIGNATURES</u> | <u>SIGNATURES</u> | <u>[5](#i3cd56b2dadf3494f902af376ecd730e3_19)</u> |
| EX-10.1 | EX-10.1 | |
| EX-99.1 | EX-99.1 | |

---

------

<u>[**Table of Contents**](#i3cd56b2dadf3494f902af376ecd730e3_7)</u>

**Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers**

*(d) Election of Directors*

On February 7, 2023, the Board of Directors (the "Board") of Lam Research Corporation (the "Company"), pursuant to applicable provisions of the Company's Amended and Restated Bylaws, appointed Ho Kyu Kang, age 61, as director of the Company, effective immediately. Dr. Kang's appointment increased the size of the board to ten members.

Dr. Kang has served as the Chair Professor in the Department of Systems Semiconductor Engineering at Yonsei University since March 2021. Prior to his current position, Dr. Kang served as Executive Vice President and Head of Research at the Semiconductor R&D Center of Samsung Electronics Co., Ltd., ("Samsung"), a manufacturer of consumer electronics, information technology and mobile communications products, and semiconductor devices, from 2017 to 2021. Before that, he served as Executive Vice President and leader of process development at the Semiconductor R&D Center from 2015 to 2017, as Senior Vice President and team leader from 2010 to 2015, and as Vice President responsible for the system large-scale integration process architecture team and advanced technology development from 2003 to 2010. Dr Kang joined Samsung as a research and development engineer in 1985. He is the author or co-author of numerous international papers.

Dr. Kang previously served as a member of the board of directors of the Semiconductor Research Corporation (SRC), a U.S.-based, non-profit, multinational research and development consortium, from 2017 to 2020, and as a member of the board of directors of SEMATECH, a U.S.-based, non-profit, multinational research and development consortium, from 2010 to 2015.

Dr. Kang earned a Ph.D. in material science and engineering from Stanford University, a M.S. degree in material science and engineering from Korea Advanced Institute of Science and Technology (KAIST), and a B.S. degree in metallurgical engineering from Hanyang University.

There are no arrangements or understandings between Dr. Kang and any other persons pursuant to which Dr. Kang was named director of the Company. Dr. Kang does not have any family relationship with any of the Company's directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Dr. Kang does not have a direct or indirect material interest in any transaction or proposed transaction required to be reported under Section 404(a) of Regulation S-K or Item 5.02(d) of Form 8-K.

Dr. Kang will receive compensation for his service as a director consistent with the Company's current policies for compensation of non-employee directors.

In accordance with the Company's customary practice, the Company is entering into its standard form of indemnification agreement with Dr. Kang, which will require the Company to indemnify him against certain liabilities that may arise as a result of his status or service as a director. The description of the indemnification agreement with Dr. Kang is qualified in its entirety by the full text of the form of indemnification agreement, which is attached to the Company's Quarterly Report on Form 10-Q dated April 24, 2017 as Exhibit 10.1.

On February 9, 2023, the Company issued a press release announcing Dr. Kang's appointment. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

*(e) Compensatory Arrangements of Certain Officers*

On February 7, 2023, the Compensation and Human Resources Committee (the "Committee) of the Board amended and restated the 2004 Executive Incentive Plan (as amended and restated, the "Plan") under which executive officers and senior management of the Company may receive performance-based incentive compensation in the form of cash payments or stock awards. The Plan is effective as of February 7, 2023. The Plan was amended to (i) clarify that awards granted under the Plan are subject to the Company's clawback policy, (ii) remove certain provisions that were related to compliance with the performance-based compensation exception under Section 162(m) of the Internal Revenue Code of 1986, as amended, reflecting the repeal of that exception under the Tax Cuts and Jobs Act of 2017, and (iii) make certain other administrative changes.

The preceding summary of the Plan is qualified in its entirety by reference to the full text of such Plan, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

------

<u>[**Table of Contents**](#i3cd56b2dadf3494f902af376ecd730e3_7)</u>

**Item 9.01. Financial Statements and Exhibits** 

*(d) Exhibits*

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| 10.1 | <u>[2004 Executive Incentive Plan, as Amended and Restated](lrcx_exx101x2004eipamended.htm)</u> |
| 99.1 | <u>[Press Release dated February 9, 2023](lrcx_exx991xprfebruary2023.htm)</u> |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |

---

------

<u>[**Table of Contents**](#i3cd56b2dadf3494f902af376ecd730e3_7)</u>

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 9, 2023 |  | **LAM RESEARCH CORPORATION** |
|  |  |  | (Registrant) |
|  |  | By: | /s/ Ava M. Hahn |
|  |  |  | **Ava M. Hahn** |
|  |  |  | **Senior Vice President, Chief Legal Officer** |

---

## Exhibit 10.1

**Exhibit 10.1**

**LAM RESEARCH CORPORATION<br>2004 EXECUTIVE INCENTIVE PLAN**

**Amended and Restated**

**Effective as of February 7, 2023**

&nbsp;&nbsp;&nbsp;&nbsp; The Compensation and Human Resource Committee (the "Committee") of the Board of Directors of Lam Research Corporation ("Company") hereby adopts this amended and restated version of the 2004 Executive Incentive Plan ("Plan"), effective as of February 7, 2023.

***1. Purpose.***

&nbsp;&nbsp;&nbsp;&nbsp; The purpose of the Plan is to provide performance-based incentive compensation in the form of cash payments or stock awards to executive officers and senior management of the Company and any affiliates which might subsequently adopt the Plan.

***2. Administration.***

&nbsp;&nbsp;&nbsp;&nbsp; The Plan has been established by, and shall be administered by, the Committee.

***3. Participants.***

&nbsp;&nbsp;&nbsp;&nbsp; For each measurement period (which may but need not be a fiscal year), the Committee will choose, in its sole discretion, those eligible employees who will participate in the Plan during that measurement period and will be eligible to receive payment under the Plan for that measurement period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***a)Eligible Employees.*** Persons who are eligible to participate in the Plan are all members of senior management of the Company and its affiliates. For purposes of the Plan, senior management is defined as any officer who is subject to the reporting rules of Section 16(a) of the Securities Exchange Act of 1934, or who is designated as eligible for the Plan by the Committee in its discretion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***b)Employment Criteria.*** In general, to participate in the Plan an eligible employee must be continuously employed by the Company or an affiliate for the entire measurement period. The foregoing notwithstanding: (i) if an otherwise eligible employee joins the Company or an affiliate during the measurement period, the Committee may, in its discretion, add the employee to the Plan for the partial measurement period, and (ii) if the employment of an otherwise eligible employee ends before the end of the measurement period because of death, disability or termination of employment (as determined in the discretion of the Committee), the employee shall be paid a pro-rata portion of the compensation, if any, that otherwise would have been payable under the Plan based upon the actual achievement of the performance goals applicable during the measurement period in which termination of employment occurs, unless the Committee determines in its sole discretion that payment is not appropriate. If a participant is on unpaid leave status for any portion of the measurement period, the Committee, in its discretion, may reduce the participant's payment on a pro-rata basis.

All determinations under the Plan, including those related to interpretation of the Plan, eligibility, or the payment or pro-ration of any payment shall be made by the Committee pursuant to the above terms, and those determinations shall be final and binding on all employees.

------

***4. Awards.***

&nbsp;&nbsp;&nbsp;&nbsp; The Committee shall determine the size and terms of an individual award that can be made in cash or stock. Stock awards may be made pursuant to, from and in such forms permitted under any stock option, equity incentive or similar plan adopted by the Company's Board of Directors and approved by its stockholders. The stock awards shall be granted and/or vested based upon the attainment of performance goals as set forth in Section 5.

***5. Business Criteria on Which Performance Goals Shall be Based.*** 

&nbsp;&nbsp;&nbsp;&nbsp; Payment under the Plan shall be based on the Company's attainment of performance goals based on one or more of the following business criteria: Either individually, alternatively or in any combination, applied to either the Company as a whole or to a business unit, affiliate or business segment, either individually, alternatively or in any combination, and measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to previous years' results, or to a designated comparison group, peer index or fund, in each case as specified by the Committee in the award, and may include actual, growth, or performance-to-target for performance criteria selected by the Committee including, but not limited to, the following: (i) cash flow, including free cash flow and operating cash flow; (ii) earnings (including revenue; gross margin; operating profit; earnings before interest, taxes and depreciation; earnings before interest and taxes; earnings before taxes; net earnings; and special or extraordinary items) or earnings per share; (iii) stock or market price; (iv) return on equity or average shareholders' equity; (v) total stockholder value or return; (vi) return on capital; (vii) return on assets or net assets; (viii) return on investment or invested capital; (ix) return on sales; (x) income, net income, operating income, net operating income, net operating profit, controllable profits, pre-tax profit or operating margin (with or without regard to amortization/impairment of goodwill); (xi) market share or applications won; (xii) operational performance, including orders, backlog, deferred revenues, revenue per employee, overhead, days sales outstanding, inventory turns, or other expense levels; (xiii) minimum cash balances; (xiv) asset turns; (xv) product or technological developments; (xvi) customer satisfaction management by objectives; (xvii) individual management by objectives; (xviii) economic value added; and (xix) strategic plan development and implementation (including individually designed goals and objectives that are consistent with the participant's specific duties and responsibilities and that are designed to improve the organizational performance of the Company, an affiliate, or a specific business unit thereof and that are consistent with and derived from the strategic operating plan of the Company, an affiliate or any of their business units for the applicable performance period). The Committee may measure, as applicable, any of the above on a pro forma, GAAP or non-GAAP basis and may, without limitation, appropriately adjust any evaluation of performance under the business criteria to exclude any of the following events or other events, in its discretion, that occur during a performance period: (A) asset write-downs; (B) litigation or claim judgments or settlements; (C) the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results; (D) accruals for reorganization and restructuring programs; and (E) any extraordinary non-recurring items as described in FASB Accounting Standards Codification 225 and/or in management's discussion and analysis of financial condition and results of operations appearing in the Company's annual report to stockholders for the applicable year.

***6. Establishing Performance Goals.***

&nbsp;&nbsp;&nbsp;&nbsp; The Committee shall establish, for each measurement period:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***a)***the length of the measurement period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***b)***the specific business criterion or criteria, or combination thereof, that will be used;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***c)***the specific performance targets that will be used for the selected business criterion or criteria;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***d)***any special adjustments that will be applied in calculating whether the performance targets have been met to factor out extraordinary items;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***e)***the formula for calculating compensation eligible for payment under the Plan in relation to the performance targets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***f)***the eligible employees who will participate in the Plan for that measurement period; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***g)***if applicable, the target amounts for each participant for the measurement period.

***7. Determination of Attainment of Performance Goals.***

&nbsp;&nbsp;&nbsp;&nbsp; The Committee shall determine, pursuant to the performance goals and other elements established pursuant to section 5 of the Plan and other factors, in its discretion, the amounts to be paid to each employee for each measurement period or the extent to which awards have vested. The Committee's determinations shall be final and binding on all participants. However, with respect to the Chief Executive Officer and Executive Chairman (if any), the Company's outside directors shall be entitled (but are not required) to review and approve (by majority vote) the Committee's determination. These determinations must be certified in writing before payments are made, which requirement may be satisfied by approved minutes of the Committee meeting setting out the determinations made.

***8. Amendments.***

&nbsp;&nbsp;&nbsp;&nbsp; The Committee may not amend or terminate the Plan so as to increase, reduce or eliminate awards under the Plan for any given measurement period retroactively, that is, on any date later than 90 days after the start of the measurement period (although, for the avoidance of doubt, this provision shall not impact the Committee's ability to use negative discretion). The Committee may amend or terminate the Plan at any time on a prospective basis and/or in any fashion that does not increase, reduce or eliminate awards retroactively.

***9. Time and Form of Payment.***

&nbsp;&nbsp;&nbsp;&nbsp; All payments in respect of awards granted under this Plan shall be made in cash on or before March 15th of the year following the year in which the measurement period ends. The Committee may also provide for payment in the form of shares or share awards as provided in Section 4.

***10. Section 409A of the Code.***

&nbsp;&nbsp;&nbsp;&nbsp; Awards under the Plan are intended to comply with Section 409A of the Code and all awards shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the effective date of the Plan. Notwithstanding any provision of the Plan or any Award to the contrary, in the event that the Committee determines that any Award may or does not comply with Section 409A of the Code, the Company may adopt such amendments to the Plan and the affected Award (without employee consent) or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Committee determines are necessary or appropriate to (i) exempt the Plan and any award from the application of Section 409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to Award, or (ii) comply with the requirements of Section 409A of the Code.

------

Notwithstanding any provisions of this Plan to the contrary, if an employee is a "specified employee" (within the meaning of Section 409A of the Code and determined pursuant to policies adopted by the Company) on the employee's date of separation from service and if any portion of an award to be received by the employee upon the employee's separation from service would be considered deferred compensation under Section 409A of the Code, amounts of deferred compensation that would otherwise be payable pursuant to this Plan during the six-month period immediately following the employee's separation from service will instead be paid or made available on the earlier of (i) the first day of the seventh month following the date of the Participant's separation from service and (ii) the employee's death. In the event that payments are delayed pursuant to this section, then such payments shall be paid at the time specified in this section without interest. The Company shall consult with the employee in good faith regarding the implementation of the provisions of this section, provided that neither the Company nor any of its employees or representatives shall have any liability to the employee with respect thereto. Any amount under this program that satisfies the requirements of the "short-term deferral" rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute a deferred payment for purposes of this Plan. Any amounts scheduled for payment hereunder when they are ordinarily paid, will nonetheless be paid to employee on or before March 15th of the year following the year when the payment is no longer subject to a substantial risk of forfeiture. For purposes of Section 409A of the Code, the right to a series of installment payments shall be treated as a right to a series of separate payments, and references herein to the employee's termination of employment shall refer to employee's separation of services with the Company within the meaning of Section 409A of the Code.

***11. Rule 10b5-1 Trading Plans; Stock Withholding.***

&nbsp;&nbsp;&nbsp;&nbsp; It is expected that participants under the Plan will establish or modify stock trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, to provide for the sale of Company shares and remit to the Company the proceeds to meet the Company's withholding obligations in connection with stock awards hereunder. To the extent participants fail to establish or modify 10b5-1 plans in accordance with the foregoing, the Company at its election shall either require the participant to pay cash sufficient to meet the withholding obligation or the Company shall withhold the number of shares under a stock award sufficient (based on the fair market value of the Shares) to meet such withholding obligation.

***12. Effect on Employment/Right to Receive.***

&nbsp;&nbsp;&nbsp;&nbsp; Employment with the Company and its affiliates is on an at-will basis. Nothing in the Plan shall interfere with or limit in any way the right of the Company to terminate any participant's employment or service at any time, with or without cause or notice. Furthermore, the Company expressly reserves the right, which may be exercised at any time and without regard to any measurement period, to terminate any individual's employment with or without cause, and to treat the individual without regard to the effect which such treatment might have upon the individual as a participant under this Plan. For purposes of this Plan, transfers of employment between the Company and/or its affiliates shall not be deemed a termination of employment. No person shall have the right to be selected to receive a Stock Award under the Plan, or, having been so selected, have the right to receive a future award.

***13. Successors.***

&nbsp;&nbsp;&nbsp;&nbsp; All obligations of the Company under the Plan, with respect to awards granted hereunder, shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all the business or assets of the Company.

------

***14. Nontransferability of Awards.***

&nbsp;&nbsp;&nbsp;&nbsp; No award granted under this Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will, by the laws of descent and distribution, or to the extent permitted by the Company's 2007 Stock Incentive Plan, 2015 Stock Incentive Plan or other equity plan, to the extent an award is payable from such plans. All rights with respect to an award granted under this Plan shall be available during the lifetime of a participant only to the participant to whom the award under this Plan is granted.

***15. Compensation Recovery/Clawback Provisions.***

&nbsp;&nbsp;&nbsp;&nbsp; Awards granted under this Plan shall be subject to any applicable compensation recovery or clawback policy adopted by the Company.

## Exhibit 99.1

**Exhibit 99.1**

![image_0.jpg](image_0.jpg)

<br>**Lam Research Appoints Semiconductor Engineering Leader Dr. Ho Kyu Kang** 

**to Board of Directors**

<br> **FREMONT, Calif., February 9, 2023** – Lam Research Corporation (NASDAQ: LRCX) today announced that Dr. Ho Kyu Kang has joined its board of directors, effective February 7, 2023. Dr. Kang brings to Lam four decades of experience in leading-edge semiconductor engineering and development.

Dr. Kang is currently the Chair Professor of the Department of Systems Semiconductor Engineering at Yonsei University in Seoul, South Korea. Previously, he was an executive vice president of Samsung Electronics Co., Ltd. and served as Head of Research at the Samsung Semiconductor R&D Center from 2017 to 2020. During his distinguished 35-year career at Samsung, Dr. Kang held a range of leadership positions and drove the development of multiple generations of logic and 2D and 3D memories. He was also responsible for system large-scale integration (LSI) process architecture and key advancements in CMOS image sensor processes. In addition, he oversaw research into future semiconductor technologies and convergence for Samsung, including the exploration of next-generation materials and semiconductor tools.

"We are proud to welcome Dr. Ho Kyu Kang to our board," said Abhijit Talwalkar, chairman of the board at Lam Research. "As one of the world's foremost experts in the development of advanced chip technologies and processes, Dr. Kang brings a wealth of experience and expertise in logic, flash and DRAM engineering, and will provide valuable insight as we continue to help our customers realize their next-generation product roadmaps in the 3D era."

------

governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022 and our quarterly report on Form 10-Q for the fiscal quarter ended December 25, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

\# \# \#

**Company Contacts** <br>Laura Bakken

Public Relations

(510) 972-5029

publicrelations@lamresearch.com <br>Ram Ganesh<br>Investor Relations<br>(510) 572-1615<br>investor.relations@lamresearch.com

<br>